Abstract

The aim of any quantitative structure-activity relationship (QSAR) study is not only to reveal relationships between structure of molecules and their biological activity, but also to explain it within the bounds of theoretical conceptions and to use the obtained model for prediction of properties of new compounds. That provides possibility to execute directed synthesis of new compounds with required biological activities. Monocarboxylate transporter 1 (MCT1) is one of the targets in a search for new immune response modulating and antitumor agents. In the present study, QSAR model for MCT1 binding affinity is developed. Decisive influence of relative negative partial charge, solvation energy, and radius of gyration on MCT1 inhibition has been detected. Theoretical explanation of the obtained model is given, and biological activity prediction for a series of N-vinyl derivatives of thieno[2,3-d]pyrimidine-2,4-dione is made. Directed synthesis of three leading compounds has been executed according to prediction results.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.